IFNA2, interferon alpha 2, 3440

N. diseases: 355; N. variants: 1
Disease: Myelofibrosis ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0026987
Disease: Myelofibrosis
Myelofibrosis 		0.020 Biomarker disease BEFREE Benefits and pitfalls of pegylated interferon-α2a therapy in patients with myeloproliferative neoplasm-associated myelofibrosis: a French Intergroup of Myeloproliferative neoplasms (FIM) study. 29217781 2018
CUI: C0026987
Disease: Myelofibrosis
Myelofibrosis 		0.020 Biomarker disease BEFREE We report the preliminary results from a phase II study of CT with pegylated interferon-α2 and ruxolitinib in 50 MPN patients (PV, n = 32; low-/intermediate-1-risk MF, n = 18), the majority (n = 47) being resistant and/or intolerant to interferon-α2 monotherapy. 29932310 2018